Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Regulation

Pharmacy technician warned after class A drugs and racial assault

A pharmacy technician has been slapped with a warning by the regulator after a “racially aggravated assault” and admitting to using “class A illegal drugs”, it has revealed.

GPhC Crime

PDA slams 'disingenuous' RPS as P-med self-selection row rages on

The pharmacists’ trade union has called on members to share their views on P-med self-selection citing “several concerns” with the royal society’s discussion on the controversial topic.

Medicines General Regulation

MHRA approves weight loss jab Wegovy to ‘prevent’ heart problems in UK ‘first’

The medicines regulator has approved the use of semaglutide injections to “reduce the risk” of “serious heart problems” in overweight adults. 

Cardiovascular Medicines

‘Incredible waste of talent’: PDA slams GPhC for ‘failing’ black students

The Pharmacists’ Defence Association (PDA) has said that the regulator has “failed” black students in its response to a GPhC pharmacy education consultation.   

GPhC Education

GPhC to hold ‘confidential’ discussions on racism, registration and FtP suicides

The pharmacy regulator has revealed it will discuss items normally debated in public, as well as reports of deaths by suicide while under fitness-to-practise investigation by another regulator, in a confidential session at its upcoming council meeting.

GPhC People

GPhC ‘looking at’ sexual misconduct process after C+D exposé

The regulator has said it will examine how it handles fitness-to-practise (FtP) sexual misconduct cases and initial allegations following a C+D investigation. 

People GPhC

Pharmacist suspended for WhatsApp remote supervision while ‘in lavatory’

An “inexperienced” pharmacist has been suspended for “running [a] pharmacy using Whatsapp” and allowing drugs to be dispensed without a pharmacist on site, the General Pharmaceutical Council (GPhC) has revealed.

GPhC People

RPS launches call for evidence on P-med self-selection amid controversy

The Royal Pharmaceutical Society (RPS) has announced a call for evidence on the self-selection of Pharmacy medicines (P-meds) to help it “consider” its position on the matter.

Medicines General Regulation

‘Limitless’ online drug availability puts lives ‘at risk’, coroner warns after death

A coroner has demanded tighter regulation after an "elite" army veteran overdosed on drugs he bought through an “online company”. 

Digital Medicines

Novo Nordisk rapped by advertising regulator after £7.8m irregular payments

The pharmaceutical giant admitted failing to disclose the payments from 2020-2022 which had been “incorrectly categorised in finance systems as a result of human error”.

Manufacturers Money

Four ‘pending’ prosecutions in NI over illicit weight loss drugs

Northern Ireland health minister Mike Nesbitt has revealed that the country has successfully prosecuted one person, with four more “pending”, on charges related to weight loss drug supply.

Lifestyle Crime

‘A serious breach’: Pharmacist warned over sexual relationship with patient

The regulator has warned a pharmacist to maintain “boundaries” after she entered a relationship with a patient.  

GPhC People
See All
UsernamePublicRestriction

Register